-
Biotech Top Gainers – Ariad Pharmaceuticals (NASDAQ:ARIA), Inovio Pharmaceuticals (NYSEMKT: INO), Geron Corporation (NASDAQ:GERN), ACADIA Pharmaceuticals (NASDAQ:ACAD)
Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA continue to move higher on Monday morning following Friday’s decision by the U.S. Food and Drug Administration (FDA) to reinstate the company’s leukemia drug Iclusig to the market, albeit for a much smaller population of patients. Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) closed at $ 7.00 during last trading…
-
Biotechnology Stocks Swing On Major News: Gilead Sciences, HCA Holdings, Tenet Healthcare, Spectrum Pharmaceuticals, MannKind, Sequenom, ACADIA Pharmaceuticals, Dendreon, Community Health Systems
Gilead Sciences, Inc. (NASDAQ:GILD) expected to hold European Society of Cardiology Congress 2013 on Aug 31, 2013. The has the market capitalization of $87.16 billion, enterprise value of $93.52 billion. The company has the price over sales value of $8.76 whereas its price over book value of $8.58 for the most recent quarter. HCA Holdings…
-
Seven Emerging Biotechnology Stocks Fighting With Bulls: Insmed, Inovio, MannKind, ACADIA , Alexion , Arena Pharmaceuticals,
The effect of a treatment on in general endurance and progression-free endurance are attributes that the majority influence the prescribing choices of surveyed U.S. and European oncologists surveyed by health care consultative company Decision Resources for second-line metastatic colorectal cancer. Insmed Incorporated (NASDAQ:INSM) reported that it is proposing $60M of its common stock and aims…
-
Biotech Captures Street Intensions: Celgene, Merrimack Pharmaceuticals, Rockwell Medical, AVEO Pharmaceuticals, Edwards Lifesciences, Medtronic, AngioDynamics, ACADIA Pharmaceuticals, BioMarin Pharmaceutical, Exelixis,
Celgene Corporation (NASDAQ:CELG) reported that a Phase 3 study of its flagship blood-cancer drug Revlimid, in mixture with dexamethasone, got together its primary endpoint of progression-free survival in enduring recently diagnosed with multiple myeloma. The biopharmaceutical firm declared that it will begin debate with regulatory authorities and plans to present dossiers for registration in the…
-
U.S. and India Sign a MoU to Co-operate in the Field of Biotechnology – (CTIC, QCOR, GILD, ACAD)
The US-based Washington Biotechnology and Biomedical Association (WBBA) and the Association of Biotechnology Led Enterprises (ABLE), a consortium of Indian biotechnology companies, have reportedly signed a memorandum of understanding (MoU) with an aim to enable broad ranging co-operation in the field of biotechnology. The tie-up is expected to support breakthrough discoveries in different field including…